Skip to main content

Table 1 Mean bodyweight at baseline, week 16 and corresponding differences with confidence intervals

From: Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [177Lu]Lu-DOTA-TATE in Lewis rats

Bodyweight (g)BaselineWeek 16Difference (%)
Placebo204.0 ± 7.5230.2 ± 10.512.8 ± 2.7
Everolimus204.7 ± 5.2222.9 ± 5.69.0 ± 2.9
Placebo + [177Lu]Lu-DOTA-TATE208.4 ± 3.8230.5 ± 10.110.6 ± 4.5
Everolimus + [177Lu]Lu-DOTA-TATE208.4 ± 4.5221.1 ± 10.86.0 ± 4.0